相关实验视频
Updated: Jul 1, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
383
目前和新兴的药理疗法用于库辛病
Efstathios Divaris1, Georgios Kostopoulos1, Zoe A Efstathiadou1
1Department of Endocrinology, "Hippokration" General Hospital of Thessaloniki, Thessaloniki, Greece.
Current pharmaceutical design
|February 29, 2024
概括
由于高死亡率,库辛病 (CD) 管理需要及时治疗. 本综述涵盖了当前的疗法,临床试验,以及用于有效治疗CD的新兴分子标.
科学领域:
- 内分泌学 在内分泌学.
- 神经内分泌学神经内分泌学
- 在瘤学瘤学.
背景情况:
- 库辛病 (Cushing's Disease,简称CD) 是由 pituitary ACTH 分泌的瘤引起的,导致高皮质醇症.
- 未经治疗的CD显著增加了发病率和死亡率.
- 神经外科手术是主要的治疗方法,但30%的患者患有持续性疾病.
研究的目的:
- 审查目前和新兴的库辛病治疗方法.
- 讨论药物治疗和辐射作为二线和三线选择.
- 基于最近的分子发现,探索新的治疗点.
主要方法:
- 对CD的既定和正在研究的治疗方法的文献综述.
- 在CD中,下丘脑-垂体-上腺轴背后的分子机制的分析.
- 在正在进行的临床试验中讨论化合物.
主要成果:
- 神经外科提供治疗潜力,但有局限性.
- 药物治疗和放射治疗对于持久性或复发性CD至关重要.
- 了解CD病理生理学的进步揭示了新的治疗途径.
结论:
- 库辛病的有效管理需要一个多方面的治疗方法.
- 对分子点的持续研究有望改善治疗策略.
- 个性化治疗计划对于优化CD患者的治疗结果至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Adrenal Gland Disorders
1.5K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
166
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
166
Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K

